Peptide Injections

A peptide injection delivers a synthetic peptide — a short chain of amino acids — directly into the body using a small needle, typically an insulin syringe with a 29- to 31-gauge needle. The vast majority of peptide shots are subcutaneous (subQ), meaning the needle is inserted into the fatty tissue just beneath the skin rather than into the muscle.

Subcutaneous injection is the standard route for most research and therapeutic peptides because it provides steady, predictable absorption. The peptide diffuses from the fatty tissue into nearby capillaries and then into the bloodstream over minutes to hours, creating a sustained release effect that closely mirrors natural hormone pulsatility.

Peptide injections are used in clinical and wellness settings for a wide range of goals including tissue repair and recovery, growth hormone optimization, weight loss, immune support, anti-aging, and sexual health. They require reconstitution before use — the peptide ships as a freeze-dried powder and must be mixed with bacteriostatic water to create an injectable solution.

Peptide injections work by delivering a precise dose of a synthetic peptide directly into the body, bypassing the digestive system entirely. Once injected, the peptide enters the bloodstream and binds to specific receptors on target cells, triggering biological responses such as growth hormone release, tissue repair signaling, appetite regulation, or immune modulation.

Subcutaneous vs. Intramuscular Injections

Subcutaneous (subQ) injection is the standard for most peptides. The needle is inserted at a 45- to 90-degree angle into the fatty tissue just beneath the skin. SubQ injection provides slower, more sustained absorption — peptides diffuse from the fatty tissue into capillaries over minutes to hours. This makes subQ ideal for peptides that benefit from steady, pulsatile release such as growth hormone secretagogues (CJC-1295, Ipamorelin, Sermorelin) and GLP-1 agonists (Semaglutide, Tirzepatide).

Intramuscular (IM) injection delivers the peptide directly into muscle tissue, where blood flow is higher and absorption is faster. IM injection is less common for peptides but is used for specific compounds like PEG-MGF and IGF-1 LR3, which target localized muscle growth. IM injection uses slightly longer needles (typically 25-gauge, 1 inch) and is injected into the deltoid, vastus lateralis (outer thigh), or gluteal muscles.

Why Subcutaneous Is Most Common

• Slower absorption creates a sustained release profile that mimics natural hormone pulsatility
• Shorter, thinner needles (29–31 gauge) reduce discomfort
• Fewer nerve endings in fatty tissue mean less pain
• Lower risk of hitting blood vessels or nerves compared to IM
• Easy to self-administer at home without assistance

Most injectable peptides ship as a freeze-dried (lyophilized) powder in a sealed vial. Before you can inject, you need to reconstitute the peptide — add bacteriostatic water to the vial to create an injectable solution — then calculate how many units on your syringe correspond to your desired dose.

Most therapeutic peptides must be injected because the gastrointestinal tract destroys them before they can reach the bloodstream. The stomach’s acidic environment (pH 1.5–3.5) denatures the three-dimensional structure that gives a peptide its biological activity. Digestive enzymes — pepsin in the stomach, trypsin and chymotrypsin in the small intestine — then cleave the remaining peptide bonds. The result is that unmodified oral peptides typically have less than 1% bioavailability.

Injection bypasses all of these barriers. A subcutaneous peptide injection delivers the full dose directly into the body with near 100% bioavailability, producing predictable and consistent blood levels.

Exceptions: Peptides That Can Be Taken Orally

A small number of peptides have been formulated for oral use through protective technologies:

• Oral Semaglutide (Rybelsus) — uses a SNAC (sodium salcaprozate) absorption enhancer that raises local pH and increases membrane permeability in the stomach
• Oral BPC-157 — the arginine salt form shows stability in acidic conditions and is often preferred for GI-specific applications
• MK-677 (Ibutamoren) — technically a non-peptide growth hormone secretagogue designed for oral use
• Enclomiphene — a non-peptide SERM, taken orally for testosterone support

For most peptides, injection remains the only viable route for reliable systemic delivery.